SLC5A2 and acute kidney injury: Another safety concern is that SGLT-2 inhibitors may possibly increase the risk for acute kidney injury by inducing volume depletion, but some recent studies are suggesting the opposite, showing SGLT-2 inhibitor therapy to be associated with a lower incidence of acute kidney injury [29].